A functional genomics predictive network model identifies regulators of inflammatory bowel disease

References 78

1. 1.

   Liu JZ, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979-986.

   Not in our library10.1038/ng.3359

2. 2.

   Jostins L, et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.

   Not in our library10.1038/nature11582

3. 3.

   Franke A, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.

   Not in our library10.1038/ng.717

4. 4.
   A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci · 2012

   No notice
5. 5.

   Chen GB, et al. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and Immunochip data. Hum Mol Genet. 2014;23:4710-4720.

   Not in our library10.1093/hmg/ddu174

6. 6.

   Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.

   Not in our library10.1038/nature10209

7. 7.

   Chen Y, et al. Variations in DNA elucidate molecular networks that cause disease. Nature. 2008;452:429-435.

   Not in our library10.1038/nature06757

8. 8.

   Emilsson V, et al. Genetics of gene expression and its effect on disease. Nature. 2008;452:423-428.

   Not in our library10.1038/nature06758

9. 9.

   Wang IM, et al. Systems analysis of eleven rodent disease models reveals an infammatome signature and key drivers. Mol Syst Biol. 2012;8:594.

   Not in our library10.1038/msb.2012.24

10. 10.

    Zhang B, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013;153:707-720.

    Not in our library10.1016/j.cell.2013.03.030

11. 11.

    Haberman Y, et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2014;124:3617-3633.

    Not in our library10.1172/jci75436

12. 12.

    Sandborn WJ, et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med. 2012;367:1519-1528.

    Not in our library10.1056/nejmoa1203572

13. 13.

    Li Q, et al. Variants in TRIM22 that affect NOD2 signaling are associated with very-early-onset inflammatory bowel disease. Gastroenterology. 2016;150:1196-1207.

    Not in our library10.1053/j.gastro.2016.01.031

14. 14.

    Zenewicz LA, Abraham C, Flavell RA, Cho JH. Unraveling the genetics of autoimmunity. Cell. 2010;140:791-797.

    Not in our library10.1016/j.cell.2010.03.003

15. 15.

    Farh KK, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518:337-343.

    Not in our library10.1038/nature13835

16. 16.

    Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421-427.

    Not in our library10.1038/nature13595

17. 17.

    Park H, et al. A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic protein 1 in lymphopoiesis and innate immunity. J Exp Med. 2008;205:2899-2913.

    Not in our library10.1084/jem.20080340

18. 18.

    Stevenson C, et al. Essential role of Elmo1 in Dock2-dependent lymphocyte migration. J Immunol. 2014;192:6062-6070.

    Not in our library10.4049/jimmunol.1303348

19. 19.

    Kadoya M, et al. Allograft inflammatory factor-1 stimulates chemokine production and induces chemotaxis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun. 2014;448:287-291.

    Not in our library10.1016/j.bbrc.2014.04.106

20. 20.

    Dobbs K, et al. Inherited DOCK2 deficiency in patients with early-onset invasive infections. N Engl J Med. 2015;372:2409-2422.

    Not in our library10.1056/nejmoa1413462

21. 21.

    Sakai Y, et al. The Rac activator DOCK2 regulates natural killer cell–mediated cytotoxicity in mice through the lytic synapse formation. Blood. 2013;122:386-393.

    Not in our library10.1182/blood-2012-12-475897

22. 22.

    Gotoh K, et al. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. J Exp Med. 2010;207:721-730.

    Not in our library10.1084/jem.20091776

23. 23.

    Watanabe M, et al. DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation. J Immunol. 2014;193:5660-5667.

    Not in our library10.4049/jimmunol.1400885

24. 24.

    Sanui T, et al. DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1. Blood. 2003;102:2948-2950.

    Not in our library10.1182/blood-2003-01-0173

25. 25.

    Zhao YY, Yan DJ, Chen ZW. Role of AIF-1 in the regulation of inflammatory activation and diverse disease processes. Cell Immunol. 2013;284:75-83.

    Not in our library10.1016/j.cellimm.2013.07.008

26. 26.

    Fukui Y, et al. Haematopoietic cell–specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature. 2001;412:826-831.

    Not in our library10.1038/35090591

27. 27.
    Autoimmune Disease Classification by Inverse Association with SNP Alleles · 2009

    No notice
28. 28.

    Giguère PM, et al. G protein signaling modulator-3 inhibits the infammasome activity of NLRP3. J Biol Chem. 2014;289:33245-33257.

    Not in our library10.1074/jbc.m114.578393

29. 29.

    Yang ZF, et al. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int Immunol. 2005;17:1391-1397.

    Not in our library10.1093/intimm/dxh316

30. 30.

    Liu G, Ma H, Jiang L, Zhao Y. Allograft inflammatory factor-1 and its immune regulation. Autoimmunity. 2007;40:95-102.

    Not in our library10.1080/08916930601083946

31. 31.

    Kim S, et al. Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes. Nat Commun. 2014;5:5236.

    Not in our library10.1038/ncomms6236

32. 32.

    Lösing M, et al. The Dok-3/Grb2 protein signal module attenuates Lyn kinase-dependent activation of Syk kinase in B cell antigen receptor microclusters. J Biol Chem. 2013;288:2303-2313.

    Not in our library10.1074/jbc.m112.406546

33. 33.

    Ng CH, Xu S, Lam KP. Dok-3 plays a nonredundant role in negative regulation of B-cell activation. Blood. 2007;110:259-266.

    Not in our library10.1182/blood-2006-10-055194

34. 34.

    Ou X, Xu S, Li YF, Lam KP. Adaptor protein DOK3 promotes plasma cell differentiation by regulating the expression of programmed cell death 1 ligands. Proc Natl Acad Sci USA. 2014;111:11431-11436.

    Not in our library10.1073/pnas.1400539111

35. 35.

    Peng Q, O'Loughlin JL, Humphrey MB. DOK3 negatively regulates LPS responses and endotoxin tolerance. PLoS One. 2012;7:e39967.

    Not in our library10.1371/journal.pone.0039967

36. 36.

    Steinbach EC, Plevy SE. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis. 2014;20:166-175.

    Not in our library10.1097/mib.0b013e3182a69dca

37. 37.

    Mortha A, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 2014;343:1249288.

    Not in our library10.1126/science.1249288

38. 38.

    Onozawa Y, et al. Activation of T cell death-associated gene 8 regulates the cytokine production of T cells and macrophages in vitro. Eur J Pharmacol. 2012;683:325-331.

    Not in our library10.1016/j.ejphar.2012.03.007

39. 39.

    Shenoy AR, et al. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science. 2012;336:481-485.

    Not in our library10.1126/science.1217141

40. 40.

    Soucie EL, et al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells. Science. 2016;351:aad5510.

    Not in our library10.1126/science.aad5510

41. 41.

    Gemperle C, et al. Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages. PLoS One. 2012;7:e50195.

    Not in our library10.1371/journal.pone.0050195

42. 42.

    Ma C, et al. Receptor signaling lymphocyte-activation molecule family 1 (Slamf1) regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting a Beclin-1/Vps34/ultraviolet radiation resistance-associated gene (UVRAG) complex. J Biol Chem. 2012;287:18359-18365.

    Not in our library10.1074/jbc.m112.367060

43. 43.

    Duong BH, et al. A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity. Immunity. 2015;42:55-67.

    Not in our library10.1016/j.immuni.2014.12.031

44. 44.

    Glowacka WK, Alberts P, Ouchida R, Wang JY, Rotin D. LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages. J Biol Chem. 2012;287:27691-27702.

    Not in our library10.1074/jbc.m112.355917

45. 45.

    Present DH, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340:1398-1405.

    Not in our library10.1056/nejm199905063401804

46. 46.

    Ito H. Treatment of Crohn's disease with anti-IL-6 receptor antibody. J Gastroenterol. 2005;40(Suppl. 16):32-34.

    Not in our library10.1007/bf02990576

47. 47.

    Daryani NE, et al. Significance of IL-1RA polymorphism in Iranian patients with infammatory bowel disease. Dig Dis Sci. 2015;60:1389-1395.

    Not in our library10.1007/s10620-014-3457-z

48. 48.

    Mayer L, et al. Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study. Gut. 2014;63:442-450.

    Not in our library10.1136/gutjnl-2012-303424

49. 49.

    Globig AM, et al. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+ coproducing CD4+ T cells in active inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:2321-2329.

    Not in our library10.1097/mib.0000000000000210

50. 50.

    Harbour SN, Maynard CL, Zindl CL, Schoeb TR, Weaver CT. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci USA. 2015;112:7061-7066.

    Not in our library10.1073/pnas.1415675112

51. 51.

    Kinnebrew MA, et al. Interleukin 23 production by intestinal CD103+CD11b+ dendritic cells in response to bacterial fagellin enhances mucosal innate immune defense. Immunity. 2012;36:276-287.

    Not in our library10.1016/j.immuni.2011.12.011

52. 52.

    Scott CL, Aumeunier AM, Mowat AM. Intestinal CD103+ dendritic cells: master regulators of tolerance? Trends Immunol. 2011;32:412-419.

    Not in our library10.1016/j.it.2011.06.003

53. 53.

    Giguère PM, et al. G-protein signaling modulator-3, a gene linked to autoimmune diseases, regulates monocyte function and its deficiency protects from infammatory arthritis. Mol Immunol. 2013;54:193-198.

    Not in our library10.1016/j.molimm.2012.12.001

54. 54.

    Park H, Chan MM, Iritani BM. Hem-1: putting the “WAVE” into actin polymerization during an immune response. FEBS Lett. 2010;584:4923-4932.

    Not in our library10.1016/j.febslet.2010.10.018

55. 55.

    Seinen ML, van Nieuw Amerongen GP, de Boer NK, van Bodegraven AA. Rac attack: modulation of the small GTPase Rac in inflammatory bowel disease and thiopurine therapy. Mol Diagn Ther. 2016;20:551-557.

    Not in our library10.1007/s40291-016-0232-1

56. 56.

    Muise AM, et al. Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. Gastroenterology. 2011;141:633-641.

    Not in our library10.1053/j.gastro.2011.04.057

57. 57.

    Kim SS, et al. DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation. J Immunol. 2014;193:840-848.

    Not in our library10.4049/jimmunol.1301601

58. 58.

    Sironi M, et al. An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases. Mol Biol Evol. 2011;28:3319-3329.

    Not in our library10.1093/molbev/msr164

59. 59.

    Fattouh R, et al. Rac2-deficiency leads to exacerbated and protracted colitis in response to Citrobacter rodentium infection. PLoS One. 2013;8:e61629.

    Not in our library10.1371/journal.pone.0061629

60. 60.

    Muise AM, et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut. 2012;61:1028-1035.

    Not in our library10.1136/gutjnl-2011-300078

61. 61.

    Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21.

    Not in our library10.1093/bioinformatics/bts635

62. 62.

    Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923-930.

    Not in our library10.1093/bioinformatics/btt656

63. 63.

    DeLuca DS, et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics. 2012;28:1530-1532.

    Not in our library10.1093/bioinformatics/bts196

64. 64.

    McKenna A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297-1303.

    Not in our library10.1101/gr.107524.110

65. 65.

    Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.

    Not in our library10.1086/519795

66. 66.

    Zhu J, et al. An integrative genomics approach to the reconstruction of gene networks in segregating populations. Cytogenet Genome Res. 2004;105:363-374.

    Not in our library10.1159/000078209

67. 67.
    Increasing the Power to Detect Causal Associations by Combining Genotypic and Expression Data in Segregating Populations · 2007

    No notice
68. 68.

    Zhu J, et al. Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet. 2008;40:854-861.

    Not in our library10.1038/ng.167

69. 69.
    Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation · 2012

    No notice
70. 70.
    Hem-1 Complexes Are Essential for Rac Activation, Actin Polymerization, and Myosin Regulation during Neutrophil Chemotaxis · 2006

    No notice
71. 71.
    An Actin-Based Wave Generator Organizes Cell Motility · 2007

    No notice
72. 72.

    Mathelier A, et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2016;44:D110-D115.

    Not in our library10.1093/nar/gkv1176

73. 73.

    Casimiro I, Chinnasamy P, Sibinga NE. Genetic inactivation of the allograft inflammatory factor-1 locus. Genesis. 2013;51:734-740.

    Not in our library10.1002/dvg.22424

74. 74.

    Sanos SL, et al. RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22–producing NKp46+ cells. Nat Immunol. 2009;10:83-91.

    Not in our library10.1038/ni.1684

75. 75.

    Ivanov II, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121-1133.

    Not in our library10.1016/j.cell.2006.07.035

76. 76.

    Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541-546.

    Not in our library10.1038/nprot.2007.41

77. 77.

    Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993;5:1461-1471.

    Not in our library10.1093/intimm/5.11.1461

78. 78.

    Shumway RH, Stoffer DS. Time Series Analysis and Its Applications. 2000.

    Not in our library

Cited by papers we hold 9

• Extending gene set variation analysis with a reference dataset to stabilize scores · 2025
  Not checked
• Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease · 2024
  No notice
• Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer’s disease: review, recommendation, implementation and application · 2022
  Not checked
• IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies · 2021
  No notice
• A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease · 2019
  No notice
• ETIOLOGÍA Y FISIOPATOLOGÍA DE LA ENFERMEDAD INFLAMATORIA INTESTINAL · 2019
  Not checked
• Metabolites of lactic acid bacteria present in fermented foods are highly potent agonists of human hydroxycarboxylic acid receptor 3 · 2019
  Corrected
• Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells · 2018
  Not checked
• Resolution of chronic inflammatory disease: universal and tissue-specific concepts · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.